Biomimetic dual-driven STING nanoagonist orchestrates neoadjuvant mild photo-immunotherapy for fibrosarcoma.

Mater Today Bio · 2026 · PMC13320259 · PMID 42388369

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

The relative changes in mature DC proportions across treatment groups in lymph nodes showed a trend similar to that observed in tumor tissues ( Fig. 7 j, Fig.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.